Literature DB >> 20143047

The effects of drug and behavior therapy on urgency and voiding frequency.

Kathryn L Burgio1, Stephen R Kraus, Diane Borello-France, Toby C Chai, Kimberly Kenton, Patricia S Goode, Yan Xu, John W Kusek.   

Abstract

INTRODUCTION AND HYPOTHESIS: The objective of this study was to examine the effects of drug therapy alone and combined with behavioral therapy on urgency and 24-voiding frequency in women with urge-predominant incontinence and to identify predictors of change.
METHODS: A planned analysis of data from a multi-site, randomized, controlled trial (N = 307). Bladder diaries were used to document voids, incontinence, and urgency severity.
RESULTS: Urgency scores decreased significantly within both treatment groups, but changes did not differ between groups (p = 0.30). Improvement in urgency was associated with greater baseline urgency (p < 0.0001) and black ethnicity (p = 0.03). Voiding frequency increased with drug alone and decreased slightly with combined therapy (p = 0.009), and improvement was associated with combined treatment (p < 0.0001), higher baseline frequency (p < 0.0001), and lower baseline incontinence episode frequency (p = 0.001).
CONCLUSIONS: Although combined drug and behavioral therapy does not appear to improve urgency more than drug alone, it resulted in better outcomes on voiding frequency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143047      PMCID: PMC3119359          DOI: 10.1007/s00192-010-1100-x

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  25 in total

1.  The responsiveness of the OAB-q among OAB patient subgroups.

Authors:  Karin S Coyne; Louis S Matza; Christine Thompson; Zhanna Jumadilova; Tamara Bavendam
Journal:  Neurourol Urodyn       Date:  2007       Impact factor: 2.696

2.  Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study.

Authors: 
Journal:  Contemp Clin Trials       Date:  2006-06-18       Impact factor: 2.226

3.  A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials.

Authors:  Annabel Nixon; Shoshana Colman; Luann Sabounjian; Bobby Sandage; Ute E Schwiderski; David R Staskin; Norman Zinner
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

4.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

5.  Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program.

Authors:  Yanni F Yu; Michael B Nichol; Andrew P Yu; Jeonghoon Ahn
Journal:  Value Health       Date:  2005 Jul-Aug       Impact factor: 5.725

6.  Combined behavioral and drug therapy for urge incontinence in older women.

Authors:  K L Burgio; J L Locher; P S Goode
Journal:  J Am Geriatr Soc       Date:  2000-04       Impact factor: 5.562

7.  Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.

Authors:  Patricia S Goode; Kathryn L Burgio; Julie L Locher; Mary G Umlauf; L Keith Lloyd; David L Roth
Journal:  J Am Geriatr Soc       Date:  2002-05       Impact factor: 5.562

8.  Weight loss to treat urinary incontinence in overweight and obese women.

Authors:  Leslee L Subak; Rena Wing; Delia Smith West; Frank Franklin; Eric Vittinghoff; Jennifer M Creasman; Holly E Richter; Deborah Myers; Kathryn L Burgio; Amy A Gorin; Judith Macer; John W Kusek; Deborah Grady
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

9.  Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial.

Authors:  Kathryn L Burgio; Stephen R Kraus; Shawn Menefee; Diane Borello-France; Marlene Corton; Harry W Johnson; Veronica Mallett; Peggy Norton; Mary P FitzGerald; Kimberly J Dandreo; Holly E Richter; Thomas Rozanski; Michael Albo; Halina M Zyczynski; Gary E Lemack; Toby C Chai; Salil Khandwala; Jan Baker; Linda Brubaker; Anne M Stoddard; Patricia S Goode; Betsy Nielsen-Omeis; Charles W Nager; Kimberly Kenton; Sharon L Tennstedt; John W Kusek; T Debuene Chang; Leroy M Nyberg; William Steers
Journal:  Ann Intern Med       Date:  2008-08-05       Impact factor: 25.391

Review 10.  Behavioral therapies for overactive bladder: making sense of the evidence.

Authors:  Jill L Milne
Journal:  J Wound Ostomy Continence Nurs       Date:  2008 Jan-Feb       Impact factor: 1.741

View more
  5 in total

Review 1.  Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.

Authors:  Bhavan Prasad Rai; June D Cody; Ammar Alhasso; Laurence Stewart
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 2.  Combination and Novel Pharmacologic Agents for OAB.

Authors:  Whitney Clearwater; Farzaan Kassam; Arshia Aalami Harandi; Christopher F Tenggardjaja; Nitya Abraham
Journal:  Curr Urol Rep       Date:  2022-05-14       Impact factor: 3.092

Review 3.  Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.

Authors:  Reuben Olugbenga Ayeleke; E Jean C Hay-Smith; Muhammad Imran Omar
Journal:  Cochrane Database Syst Rev       Date:  2015-11-03

4.  Cholinergic Antagonists Combined with Electrical Stimulation or Bladder Training Treatments for Overactive Bladder in Female Adults: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yang Cao; Jianwei Lv; Chen Zhao; Jiayi Li; Jing Leng
Journal:  Clin Drug Investig       Date:  2016-10       Impact factor: 2.859

Review 5.  Overactive bladder - 18 years - Part I.

Authors:  Jose Carlos Truzzi; Cristiano Mendes Gomes; Carlos A Bezerra; Ivan Mauricio Plata; Jose Campos; Gustavo Luis Garrido; Fernando G Almeida; Marcio Augusto Averbeck; Alexandre Fornari; Anibal Salazar; Arturo Dell'Oro; Caio Cintra; Carlos Alberto Ricetto Sacomani; Juan Pablo Tapia; Eduardo Brambila; Emilio Miguel Longo; Flavio Trigo Rocha; Francisco Coutinho; Gabriel Favre; Jose Antonio Garcia; Juan Castano; Miguel Reyes; Rodrigo Eugenio Leyton; Ruiter Silva Ferreira; Sergio Duran; Vanda Lopez; Ricardo Reges
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.